The 9-mer WT1-derived peptide 126–134, RMFPNAPYL (RMF), has been shown to be presented by HLA-A*02:01 molecules, which induces cytotoxic CD8+ T cells to kill WT1+ and HLA-A*02:01+ tumor cells [15,16,17]. Here, HLA-A is linked to neoplasm.